Universal Vision Biotechnology , Ltd. Return on Equity

Universal Vision Biotechnology , Ltd. (3218.TWO) currently reports a ROE of 29.49%. That is above the sector sector average of 11.73%. Use the charts on this page to explore Universal Vision Biotechnology , Ltd.'s ROE history and peer comparisons.

Universal Vision Biotechnology , Ltd.'s ROE of 29.49% is higher than the its sector sector average of 11.73%. That is roughly 151.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Universal Vision Biotechnology , Ltd.'s current 29.49% should be judged against industry norms (sector average: 11.73%) and against 3218.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 29.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.73%. From there, open related valuation or income-statement pages for Universal Vision Biotechnology , Ltd., and consider following 3218.TWO for alerts when major investors trade the stock.